ANA-Negative Hydralazine-Induced Pericardial Effusion
- PMID: 29391867
- PMCID: PMC5748098
- DOI: 10.1155/2017/3521541
ANA-Negative Hydralazine-Induced Pericardial Effusion
Abstract
This case describes a patient with pericardial effusion as a phenomenon of the drug-induced lupus erythematosus (DILE) syndrome due to hydralazine. The relevance of this case report lies in the fact that although hydralazine has been a known causative agent of DILE, its presentation may involve a negative anti-nuclear antibody (ANA) study. Pericardial effusion is a documented adverse effect as a result of hydralazine use. It is typically common to screen for DILE with the serum ANA test prior to proceeding to more costly and specific tests (i.e., anti-histone antibody). As per our literature review, this is the second case of hydralazine causing DILE with a negative ANA. As in our case, although the screening serum ANA is the initial next best step for suspicion of DILE by hydralazine, it is important to consider the diagnosis without ANA positivity.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5748098/bin/CRIM2017-3521541.001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5748098/bin/CRIM2017-3521541.002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5748098/bin/CRIM2017-3521541.003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5748098/bin/CRIM2017-3521541.004.gif)
Similar articles
-
A Case of Seronegative ANA Hydralazine-Induced Lupus Presenting With Pericardial Effusion and Pleural Effusion.Cureus. 2020 Aug 18;12(8):e9831. doi: 10.7759/cureus.9831. Cureus. 2020. PMID: 32953340 Free PMC article.
-
Antinuclear antibody-negative lupus? An ominous presentation of hydralazine-induced lupus syndrome.Eur J Rheumatol. 2018 Dec;5(4):272-274. doi: 10.5152/eurjrheum.2018.18040. Epub 2018 Jun 20. Eur J Rheumatol. 2018. PMID: 30071945 Free PMC article.
-
Hydralazine Induced Lupus Syndrome Presenting with Recurrent Pericardial Effusion and a Negative Antinuclear Antibody.Case Rep Rheumatol. 2017;2017:5245904. doi: 10.1155/2017/5245904. Epub 2017 Jan 17. Case Rep Rheumatol. 2017. PMID: 28194293 Free PMC article.
-
Drug-induced lupus: an update on its dermatologic aspects.Lupus. 2009 Oct;18(11):935-40. doi: 10.1177/0961203309106176. Lupus. 2009. PMID: 19762393 Review.
-
Drug-induced lupus erythematosus.Arch Dermatol Res. 2009 Jan;301(1):99-105. doi: 10.1007/s00403-008-0895-5. Epub 2008 Sep 17. Arch Dermatol Res. 2009. PMID: 18797892 Review.
Cited by
-
Hydralazine-Induced Lupus Syndrome Manifesting as Large Pericardial Effusion.Cureus. 2020 Aug 19;12(8):e9867. doi: 10.7759/cureus.9867. Cureus. 2020. PMID: 32963908 Free PMC article.
-
A Case of Seronegative ANA Hydralazine-Induced Lupus Presenting With Pericardial Effusion and Pleural Effusion.Cureus. 2020 Aug 18;12(8):e9831. doi: 10.7759/cureus.9831. Cureus. 2020. PMID: 32953340 Free PMC article.
-
Hydralazine-induced pericardial effusion.Proc (Bayl Univ Med Cent). 2019 Jun 10;32(3):377-378. doi: 10.1080/08998280.2019.1613331. eCollection 2019 Jul. Proc (Bayl Univ Med Cent). 2019. PMID: 31384190 Free PMC article.
-
When Chest Pain Reveals More: A Case of Hydrochlorothiazide-Induced Systemic Lupus Erythematosus.Am J Case Rep. 2019 Jan 7;20:26-30. doi: 10.12659/AJCR.911380. Am J Case Rep. 2019. PMID: 30613100 Free PMC article.
-
Antinuclear antibody-negative lupus? An ominous presentation of hydralazine-induced lupus syndrome.Eur J Rheumatol. 2018 Dec;5(4):272-274. doi: 10.5152/eurjrheum.2018.18040. Epub 2018 Jun 20. Eur J Rheumatol. 2018. PMID: 30071945 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials